Microbiome as therapeutics in vesicular delivery

Gautam Singhvi; Vishal Girdhar; Shalini Patil; Gaurav Gupta; Philip M. Hansbro; Kamal Dua

doi:10.1016/j.biopha.2018.05.099

Microbiome as therapeutics in vesicular delivery

Gautam Singhvi
, Vishal Girdhar
, Shalini Patil
, Gaurav Gupta
, Philip M. Hansbro
, Kamal Dua

Birla Institute of Technology and Science Pilani
Jaipur National University
University of Technology Sydney
University of Newcastle
Hunter Medical Research Institute, Australia

Research output: Contribution to journal › Review article › peer-review

24 Scopus citations

Abstract

Microbiome refers to an ecological community of various symbiotic and pathogenic microorganisms, which plays a crucial role in human health and disease. The concept of novel drug delivery systems particularly the vesicular drug delivery systems is gaining massive attention. This emerging technology has started expanding its horizons in the area of microbiome delivery. This mini-review highlights the role of vesicular systems such as nanoparticles, liposomes etc. as a host/carrier for the microbiome in targeting various diseases. This review will be of interest for both the biological and formulation scientists to understand and explore the new vistas in the area of vesicular delivery system as carrier for microbiome delivery.

Original language	English
Pages (from-to)	738-741
Number of pages	4
Journal	Biomedicine and Pharmacotherapy
Volume	104
DOIs	https://doi.org/10.1016/j.biopha.2018.05.099
State	Published - Aug 2018
Externally published	Yes

Keywords

Biotherapeutics
Disease targeting
Microbiome
Microbiota
Vesicular drug delivery systems

Access to Document

10.1016/j.biopha.2018.05.099

Cite this

@article{301c958c454943028e1fc170e4ef4c99,

title = "Microbiome as therapeutics in vesicular delivery",

abstract = "Microbiome refers to an ecological community of various symbiotic and pathogenic microorganisms, which plays a crucial role in human health and disease. The concept of novel drug delivery systems particularly the vesicular drug delivery systems is gaining massive attention. This emerging technology has started expanding its horizons in the area of microbiome delivery. This mini-review highlights the role of vesicular systems such as nanoparticles, liposomes etc. as a host/carrier for the microbiome in targeting various diseases. This review will be of interest for both the biological and formulation scientists to understand and explore the new vistas in the area of vesicular delivery system as carrier for microbiome delivery.",

keywords = "Biotherapeutics, Disease targeting, Microbiome, Microbiota, Vesicular drug delivery systems",

author = "Gautam Singhvi and Vishal Girdhar and Shalini Patil and Gaurav Gupta and Hansbro, \{Philip M.\} and Kamal Dua",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier Masson SAS",

year = "2018",

month = aug,

doi = "10.1016/j.biopha.2018.05.099",

language = "English",

volume = "104",

pages = "738--741",

journal = "Biomedicine and Pharmacotherapy",

issn = "0753-3322",

publisher = "Elsevier Masson s.r.l.",

}

TY - JOUR

T1 - Microbiome as therapeutics in vesicular delivery

AU - Singhvi, Gautam

AU - Girdhar, Vishal

AU - Patil, Shalini

AU - Gupta, Gaurav

AU - Hansbro, Philip M.

AU - Dua, Kamal

PY - 2018/8

Y1 - 2018/8

N2 - Microbiome refers to an ecological community of various symbiotic and pathogenic microorganisms, which plays a crucial role in human health and disease. The concept of novel drug delivery systems particularly the vesicular drug delivery systems is gaining massive attention. This emerging technology has started expanding its horizons in the area of microbiome delivery. This mini-review highlights the role of vesicular systems such as nanoparticles, liposomes etc. as a host/carrier for the microbiome in targeting various diseases. This review will be of interest for both the biological and formulation scientists to understand and explore the new vistas in the area of vesicular delivery system as carrier for microbiome delivery.

AB - Microbiome refers to an ecological community of various symbiotic and pathogenic microorganisms, which plays a crucial role in human health and disease. The concept of novel drug delivery systems particularly the vesicular drug delivery systems is gaining massive attention. This emerging technology has started expanding its horizons in the area of microbiome delivery. This mini-review highlights the role of vesicular systems such as nanoparticles, liposomes etc. as a host/carrier for the microbiome in targeting various diseases. This review will be of interest for both the biological and formulation scientists to understand and explore the new vistas in the area of vesicular delivery system as carrier for microbiome delivery.

KW - Biotherapeutics

KW - Disease targeting

KW - Microbiome

KW - Microbiota

KW - Vesicular drug delivery systems

UR - https://www.scopus.com/pages/publications/85047399443

U2 - 10.1016/j.biopha.2018.05.099

DO - 10.1016/j.biopha.2018.05.099

M3 - Review article

C2 - 29807223

AN - SCOPUS:85047399443

SN - 0753-3322

VL - 104

SP - 738

EP - 741

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

ER -

Microbiome as therapeutics in vesicular delivery

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this